Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TZP-102 for diabetic gastroparesis symptoms
2012-002576-14Phase 2Terminated
- Sponsor
- Tranzyme Pharma
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic gastroparesis comparing TZP-102 with Placebo (2 arms). Primary endpoint: Change from baseline in GSDD symptom scores. Started Jul 2012; status: terminated.
02
Drugs
TZP-102
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on 2012-002576-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002576-14.